Impact of COVID-19 restrictions on pathology service utilisation.

Gillam, Marianne H; Roughead, Elizabeth; Tavella, Rosanna; Dodd, Tom; Beltrame, John; Ryan, Richard; O'Loughlin, Peter

Gillam, Marianne H; Roughead, Elizabeth; Tavella, Rosanna; Dodd, Tom; Beltrame, John; Ryan, Richard; O'Loughlin, Peter.

Afiliação

Gillam MH; The Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.
Roughead E; The Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.
Tavella R; Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
Dodd T; SA Pathology, Adelaide, South Australia, Australia.
Beltrame J; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.
Ryan R; Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
O'Loughlin P; SA Pathology, Adelaide, South Australia, Australia.

Intern Med J ; 52(1): 42-48, 2022 Jan.

Article em En | MEDLINE | ID: mdl-34432345

Assuntos

COVID-19; Idoso; Controle de Doenças Transmissíveis; Estudos Transversais; Humanos; Pandemias; SARS-CoV-2

Palavras-chave

COVID-19; pathology services; troponin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google